List of supplementary material

Kymberley Carter; Wai-Yee Cheung; Hayley A Hutchings; Greg Fegan; Gail Holland; Steve Luzio; Gareth Dunseath; Stephen Hiles; Susie Marques-Jones; John W Gregory; Danijela Tatovic; Peter Taylor; Jane Bowen-Morris; Rachel Stenson; Stephanie Hanna; Zainab Mahmood; Jennie Yang; Evangelia Williams; Timothy Tree; Ashish Marwaha; Colin M Dayan

List of supplementary material

Publication Details

Report Supplementary Material 1.: Trial sites & Principal investigators

Report Supplementary Material 2.: Visit schedule

Report Supplementary Material 3.: Blood draw schedule

Report Supplementary Material 4.: Urine collection schedule

Report Supplementary Material 5.: Trial oversight committee members

Report Supplementary Material 6.: Protocol deviations

Report Supplementary Material 7.: Supplementary analyses

Supplementary material can be found on the NIHR Journals Library report page (https://doi.org/10.3310/FQLN7416).

Supplementary material has been provided by the authors to support the report and any files provided at submission will have been seen by peer reviewers, but not extensively reviewed. Any supplementary material provided at a later stage in the process may not have been peer-reviewed.

Publication Details

Copyright

This work was produced by Carter et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.

Publisher

National Institute for Health and Care Research, Southampton (UK)

NLM Citation

Carter K, Cheung WY, Hutchings HA, et al. The efficacy and safety of ustekinumab in adolescents newly diagnosed with type 1 diabetes: the USTEK1D RCT. Southampton (UK): National Institute for Health and Care Research; 2025 Feb. (Efficacy and Mechanism Evaluation, No. 12.01.) List of supplementary material.